Study Details
ASP8825 - Pharmacokinetics study in patients with impaired renal function and haemodialysis
This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).
Clinicaltrials.gov ID
The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
Astellas Study ID
The unique identification code given by the study sponsor.
8825-CL-0012
EudraCT ID
The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).
N/A
Condition
Kidney Disease
Phase
These clinical trials are usually the first time an experimental treatment is studied in a small group of people.
Phase 1
Age
20 Years - 79 Years
Sex
Female & Male
Product
N/A
Type
A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
Interventional
Trial Dates
Feb 2008 - Oct 2008
Masking
None (Open Label)
Enrollment number
18
Pharmacokinetic (PK) Study of ASP8825 - Evaluation of pharmacokinetics in patients with impaired renal function and haemodialysis
Study summary
Study documents
Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for ASP8825 - Pharmacokinetics study in patients with impaired renal function and haemodialysis? Contact us by filling our your information to the right and we’ll respond to you.